195 related articles for article (PubMed ID: 34904932)
1. Circumventing the packaging limit of AAV-mediated gene replacement therapy for neurological disorders.
Marrone L; Marchi PM; Azzouz M
Expert Opin Biol Ther; 2022 Sep; 22(9):1163-1176. PubMed ID: 34904932
[TBL] [Abstract][Full Text] [Related]
2. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
Chamberlain K; Riyad JM; Weber T
Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
[TBL] [Abstract][Full Text] [Related]
3. AAV-based in vivo gene therapy for neurological disorders.
Ling Q; Herstine JA; Bradbury A; Gray SJ
Nat Rev Drug Discov; 2023 Oct; 22(10):789-806. PubMed ID: 37658167
[TBL] [Abstract][Full Text] [Related]
4. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
5. Adeno-associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes.
McClements ME; MacLaren RE
Yale J Biol Med; 2017 Dec; 90(4):611-623. PubMed ID: 29259525
[TBL] [Abstract][Full Text] [Related]
6. Design of AAV Vectors for Delivery of Large or Multiple Transgenes.
Patel A; Zhao J; Duan D; Lai Y
Methods Mol Biol; 2019; 1950():19-33. PubMed ID: 30783966
[TBL] [Abstract][Full Text] [Related]
7. Adeno-associated virus (AAV) gene therapy for neurological disease.
Weinberg MS; Samulski RJ; McCown TJ
Neuropharmacology; 2013 Jun; 69():82-8. PubMed ID: 22465202
[TBL] [Abstract][Full Text] [Related]
8. Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear.
Akil O
Hear Res; 2020 Sep; 394():107912. PubMed ID: 32067799
[TBL] [Abstract][Full Text] [Related]
9. Strategies to circumvent humoral immunity to adeno-associated viral vectors.
Tse LV; Moller-Tank S; Asokan A
Expert Opin Biol Ther; 2015 Jun; 15(6):845-55. PubMed ID: 25985812
[TBL] [Abstract][Full Text] [Related]
10. scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolution.
Öztürk BE; Johnson ME; Kleyman M; Turunç S; He J; Jabalameli S; Xi Z; Visel M; Dufour VL; Iwabe S; Pompeo Marinho LFL; Aguirre GD; Sahel JA; Schaffer DV; Pfenning AR; Flannery JG; Beltran WA; Stauffer WR; Byrne LC
Elife; 2021 Oct; 10():. PubMed ID: 34664552
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.
Dong JY; Fan PD; Frizzell RA
Hum Gene Ther; 1996 Nov; 7(17):2101-12. PubMed ID: 8934224
[TBL] [Abstract][Full Text] [Related]
12. New and improved AAVenues: current status of hemophilia B gene therapy.
Brimble MA; Reiss UM; Nathwani AC; Davidoff AM
Expert Opin Biol Ther; 2016; 16(1):79-92. PubMed ID: 26524468
[TBL] [Abstract][Full Text] [Related]
13. Single-Cell Quantification of Triple-AAV Vector Genomes Coexpressed in Neurons.
Maturana CJ; Verpeut JL; Engel EA
Curr Protoc; 2022 May; 2(5):e430. PubMed ID: 35616444
[TBL] [Abstract][Full Text] [Related]
14. Novel tool to quantify with single-cell resolution the number of incoming AAV genomes co-expressed in the mouse nervous system.
Maturana CJ; Verpeut JL; Kooshkbaghi M; Engel EA
Gene Ther; 2023 May; 30(5):463-468. PubMed ID: 34176926
[TBL] [Abstract][Full Text] [Related]
15. Adeno-Associated Viral Vectors as a Tool for Large Gene Delivery to the Retina.
Trapani I
Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30970639
[TBL] [Abstract][Full Text] [Related]
16. New recombinant serotypes of AAV vectors.
Gao G; Vandenberghe LH; Wilson JM
Curr Gene Ther; 2005 Jun; 5(3):285-97. PubMed ID: 15975006
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer.
Arjomandnejad M; Dasgupta I; Flotte TR; Keeler AM
BioDrugs; 2023 May; 37(3):311-329. PubMed ID: 36862289
[TBL] [Abstract][Full Text] [Related]
18. Optimization strategies and advances in the research and development of AAV-based gene therapy to deliver large transgenes.
Kolesnik VV; Nurtdinov RF; Oloruntimehin ES; Karabelsky AV; Malogolovkin AS
Clin Transl Med; 2024 Mar; 14(3):e1607. PubMed ID: 38488469
[TBL] [Abstract][Full Text] [Related]
19. Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications.
Schön C; Biel M; Michalakis S
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):343-52. PubMed ID: 25615882
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for monogenic liver diseases: clinical successes, current challenges and future prospects.
Baruteau J; Waddington SN; Alexander IE; Gissen P
J Inherit Metab Dis; 2017 Jul; 40(4):497-517. PubMed ID: 28567541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
